Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™. Affibody is developing a portfolio of innovative drug projects and, in addition, offers the half-life extension technology, Albumod™, for outlicensing. Affibody has ongoing commercial relationships with several companies including Algeta, Amylin, Sobi, GE, Daiichi-Sankyo, Daewoong and Thermo Fisher. Affibody was founded in 1998 by researchers from the Royal Institute of Technology and the Karolinska Institute and is based in Stockholm, Sweden.
View Top Employees from Affibody Medical AB| Website | http://www.affibody.se |
| Revenue | $6 million |
| Employees | 1 (1 on RocketReach) |
| Phone | +46 8 598 838 00 |
| Industry | Business Services General, Business Services |
| Competitors | Alios BioPharma, Biokine Therapeutics Ltd., Cancer Prevention Pharmaceuticals, Inc, Exponential Biotherapies, Inc., MGB Biopharma Limited |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies |
Looking for a particular Affibody Medical AB employee's phone or email?
Affibody Medical AB Questions
The Affibody Medical AB annual revenue was $6 million in 2024.
Robert Burns is the Chairman of Affibody Medical AB.
1 people are employed at Affibody Medical AB.
Affibody Medical AB is based in Ase, Vasternorrlands Lan.
The NAICS codes for Affibody Medical AB are [5417, 541, 54, 541714, 54171].
The SIC codes for Affibody Medical AB are [873, 87].
Top Affibody Medical AB Employees
